The Toronto Stock Exchange has published for comment proposed amendments to the TSX Company Manual (the Proposed Amendments).
June 13, 2016
Pfizer Canada Inc. (Pfizer) markets an extended release formulation of the drug venlafaxine hydrochloride in Canada under the name EFFEXOR XR®.
June 10, 2016
The “Paris Agreement" is being widely proclaimed as a historic deal and one that will inevitably lead to decarbonisation.
The Supreme Court of Canada dismissed an application for leave to appeal in respect of a proposed consumer class action seeking damages allegedly arising from an innovator’s use of the PM(NOC) Regulations.
June 09, 2016
Key developments that will be of interest to and affect our asset management clients, including market trends and developments in tax and buy-side regulation.
Sanofi-Aventis, Sanofi-Aventis Deutschland GmbH, and Sanofi-Aventis Canada Inc. (Sanofi) market the drug ramipril in Canada under the name ALTACE. Sanofi sells ALTACE under licence from Schering Corp.
June 06, 2016
On Monday, June 6, 2016 Norton Rose Fulbright hosted its inaugural Motion 2016 – discussing what matters in Toronto.
June 03, 2016
The Alberta Court of Queen’s Bench recently granted Suncor Energy Inc.’s application for judicial review and quashed an arbitration award about Suncor’s decision to institute a random drug and alcohol testing policy for certain employees.
The Government of Canada’s proposal to legalize marijuana for recreational use in 2017 has been the focus of considerable media attention, and has spurred the interest of individuals and companies desiring to enter the budding industry.
June 02, 2016
The Federal Court of Appeal (FCA) has clarified the requirements for a binding settlement agreement, and has stated that determination of whether settlement had been reached is to be assessed from an objective standpoint.
June 01, 2016
Try searching our global site instead